New Two-Pronged attack tested for Tough-to-Treat colon cancer
NCT ID NCT06268015
Summary
This small, early-stage study is testing a new treatment approach for people with advanced colorectal cancer that has not spread to the liver, bones, or brain. Participants first receive a combination of two immunotherapy drugs. If their cancer grows, standard chemotherapy is added to the regimen. The main goal is to see if this sequence can control the cancer and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.